Astria Therapeutics, Inc. (ATXS) Misses Q1 EPS by 13c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q1 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Copart (CPRT) call put ratio 1.8 calls 1 put a share price up 3.9%
• Dycom Industries (DY) PT Lowered to $375 at Raymond James
• Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance